What lymphoma therapy works the best after CAR T therapy fails?

Published Date: 26 Apr 2023

CAR T therapy is a lifesaver for 30 to 40% of lymphoma patients who receive it. CAR T therapy involves the removal of immune cells, and it is typically administered to lymphoma patients for whom other treatments have failed.

Read Full News

Latest News

Women Face Longer Peer Review Delays

A PLOS Biology analysis finds papers led by women spend 7%-15% longer in peer review, a delay that can undermine promotion, funding, and career advancement for clinician-researchers.

Marijuana Use Tied to More Asthma Attacks in Young Adults

Young adults with asthma who inhale marijuana have a higher likelihood of asthma attacks, a new study finds.

Butterfly Network Gets FDA Clearance for AI Ultrasound Pregnancy Tool

Butterfly Network said on Monday it received U.S. regulatory clearance for an artificial intelligence-powered ultrasound ⁠tool that can estimate gestational age, a move the...

FDA Approves Higher Dose Of Genetic Disorder Drug for SMA

The U.S. Food and Drug Administration has approved a higher dose of Biogen's spinal muscular atrophy ⁠drug Spinraza, the company said on Monday, after rejecting it last...

Separate Hiring for Abortion Doctors Barred in Sicily

Italy's Constitutional Court bars Sicily from advertising jobs reserved for health workers willing to ⁠perform abortions, but it can find alternatives to safeguard access.

Real-Time Antimicrobial Stewardship May Aid Bacteremia Care

A real-time antimicrobial stewardship intervention may increase early switches from intravenous to oral antibiotics for nonstaphylococcal bloodstream infections, without changing clinical outcomes.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Latest News

A PLOS Biology analysis finds papers led by women spend 7%-15% longer in peer review, a delay that can undermine promotion, funding, and career advancement for clinician-researchers.

Young adults with asthma who inhale marijuana have a higher likelihood of asthma attacks, a new study finds.

Butterfly Network said on Monday it received U.S. regulatory clearance for an artificial intelligence-powered ultrasound ⁠tool that can estimate gestational age, a move the...

The U.S. Food and Drug Administration has approved a higher dose of Biogen's spinal muscular atrophy ⁠drug Spinraza, the company said on Monday, after rejecting it last...

Italy's Constitutional Court bars Sicily from advertising jobs reserved for health workers willing to ⁠perform abortions, but it can find alternatives to safeguard access.

A real-time antimicrobial stewardship intervention may increase early switches from intravenous to oral antibiotics for nonstaphylococcal bloodstream infections, without changing clinical outcomes.

News All Time

World’s Best Hospitals Ranking Puts Mayo Back at No. 1

A new global hospital ranking spanning 32 countries places Mayo Clinic first and highlights strong performances from hospitals in Germany, Switzerland, and Austria.

How Babies Process Pain — and Sugar’s Role in Relieving It

Mounting evidence backs sucrose as an analgesic for newborns — yet their experience of pain remains mysterious.

Environmental Pollution From Pharmaceuticals Raises Concern

Pharmaceutical residues increasingly enter ecosystems across the drug life cycle, prompting calls for coordinated global action grounded in One Health principles.

Newer Groundwater Linked to Increased PD Risk

Drinking water sourced from newer groundwater or carbonate aquifers is linked to a significantly increased risk for Parkinson’s disease, a new study shows.

AAN Issues Guidance on Consumer Wearables in Neurologic Care

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep tracking — while cautioning that many of them are insufficiently validated.

When Hearing Fails, Vision Rehab Falls Short

Patients with hearing impairment who receive vision rehabilitation are 42% less likely than those with normal hearing to achieve a meaningful functional improvement, a recent study shows.

AHS Recommends Annual Migraine Screening for Girls and Women

A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.

Biologics Don’t Promote Respiratory Infections

Reassuring data support the safety of biologics as an option for asthma care.

Biologics, Phototherapy in Psoriasis: Cost-Benefit Compared

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Spirituality Linked to Lower Risk for Substance Misuse

Integrating spirituality into patient care might hold potential for substance use prevention and recovery, a new meta-analysis shows.

GSK Gets US FDA Approval for Expanded Use Of RSV Vaccine

British drugmaker GSK said on Friday the U.S. Food and Drug ⁠Administration has expanded the approved age range for its respiratory syncytial virus vaccine, ⁠Arexvy, to...

WHO Confirms 18 Attacks on Healthcare Sites in Iran

The World Health Organization said on Wednesday that it has verified 18 attacks on healthcare centers ⁠in Iran since the start of the U.S. and Israel war on Iran.

How Can First-Year Residents Avoid Clinical Errors?

Experts say that many early residency mistakes stem from structural factors such as workload, supervision, and training environment, rather than from individual performance.

Dry Powder Inhaler May Reduce COPD Exacerbations

In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.

Add-On Vancomycin Taper May Reduce C difficile Recurrence

In patients with a first episode or first recurrence of Clostridioides difficile infection, adding a vancomycin taper after the standard 14-day course may delay or lower the risk for recurrence.

Donna Ockenden to Lead Review of Leeds Maternity Failures

An independent review will examine maternity and neonatal services at Leeds Teaching Hospitals after repeated safety failures.

Recommended News For You

Cancer and HIV Vaccines Enter the Therapeutic Era

ALK-positive lung cancer trial results show unprecedented progression-free survival.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Cancer screening rates down among American adults

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

Recommended Articles For You

New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD) 

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond 

Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions 

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Kate Middleton Reminds Us About the Role of Privacy in Healing.

2.

Cancer patients rarely use ancestry testing.

3.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

4.

Having a tattoo could increase your risk of developing lymphoma.

5.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

1.

Exploring the Mysteries of Myxoma: A New Frontier in Medical Research

2.

Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning 

3.

Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment

4.

Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers

5.

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

4.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot